Hemodynamic and permeability characteristics of acute experimental necrotizing enterocolitis.
We examined the local hemodynamic response of intestinal loops during acute necrotizing enterocolitis (NEC) in anesthetized rabbits. NEC was induced in ileal loops by transmural injection of a solution containing casein (10 mg/ml) and calcium gluconate (50 mg/ml) acidified to pH 4.0 with propionic or acetic acid. Control loops received casein only (pH 5.0). Mucosal damage was quantified by the blood-to-lumen movement of [51Cr]EDTA, fluid shifts into the lumen, and histology. Mean arterial pressure and loop blood flow were steady over the 3-hr period, loop fluid volume decreased, and there was no evidence of necrosis or epithelial damage. In loops receiving acidified casein and calcium gluconate, there was an immediate dramatic increase in loop blood flow that returned to baseline by 50 min. In addition, loop fluid volume was dramatically increased, necrosis was noted in the form of blunting and loss of villi, and sevenfold increase in [51Cr]EDTA permeability was evident. Administration of CV 1808 (30 mg/kg/hr), a selective adenosine2 agonist, which maintained and elevated loop blood flow throughout the 3 hr protocol, failed to alter the changes in loop fluid volume or prevent necrosis. Histamine levels in loop fluid levels were significantly elevated 20-30 min after NEC induction when compared to saline controls, indicating an early activation of mucosal defenses with this luminal insult. Thus, this model of NEC is characterized by a transient, acute hyperemia, increased intestinal permeability, and histamine release. As mucosal damage was independent of ischemia and could not be prevented by vasodilatory therapy, this model supports the clinical findings that NEC is correlated with luminal factors related to feeding and independent of cardiovascular stress.
Department of Pediatrics and Pharmacology, Louisiana State University, School of Medicine, New Orlean 70112-2822.
M J
MJ
Miller
J
J
Adams
X A
XA
Gu
X J
XJ
Zhang
D A
DA
Clark
D000137:Acid-Base Imbalance / Q000503:physiopathology; D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D002364:Caseins; D002860:Chromium Radioisotopes; D004492:Edetic Acid; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced / Q000503:physiopathology*; D006439:Hemodynamics / Q000502:physiology; D006636:Histamine Release / Q000502:physiology; D007082:Ileum / Q000098:blood supply / Q000503:physiopathology*; D008297:Male; D010539:Permeability; D011817:Rabbits; D012039:Regional Blood Flow; D014665:Vasodilator Agents / Q000494:pharmacology
D002364:Caseins; D002860:Chromium Radioisotopes; D014665:Vasodilator Agents; D004492:Edetic Acid; C026708:2-phenylaminoadenosine; D000241:Adenosine